Atopix raises additional development capital to investigate OC459 for … – News-Medical.net


News-Medical.net

Atopix raises additional development capital to investigate OC459 for
News-Medical.net
Atopix Therapeutics Limited ("Atopix"), a UK biopharmaceutical company developing a novel class of medicines to treat atopic dermatitis and severe asthma, today announced that it has raised additional development capital to advance its lead product …

and more »

View full post on asthma – Google News